Enzo Biochem (ENZ) has provided an update.
Enzo Biochem, Inc. has recently ramped up its commitment to Chief Financial Officer Patricia Eckert, boosting her base salary to $300,000 and granting her options for 100,000 shares at $2.00 each. This move, part of a new employment agreement, sees Eckert’s remuneration package expand with the potential for annual bonuses and additional equity grants. Stock options will vest over three years, reinforcing the company’s strategy to retain key financial leadership.
For detailed information about ENZ stock, go to TipRanks’ Stock Analysis page.
